Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 2005 September;17(3) > Minerva Biotecnologica 2005 September;17(3):127-31

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA BIOTECNOLOGICA

A Journal on Biotechnology and Molecular Biology


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246


eTOC

 

  MEDICINAL PLANTS FOR BIOTECHNOLOGY AND BIOMEDICINE


Minerva Biotecnologica 2005 September;17(3):127-31

language: English

The role of metabolic engineering for the production of secondary metabolites of plants

Khan M. T. H. 1, 2, Ather A. 2, Gambari R. 2, 3

1 Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong, Bangladesh;
2 ER-GenTech, Department of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy;
3 Biotechnology Center, University of Ferrara, Ferrara, Italy


Full text temporarily not available online. Contact us  


Plants are very interesting and useful sources of molecules of great importance for the development of new pharmaceutical products. Metabolic engineering has proven to be a valuable tool for large production of several biomedically as well as industrially relevant compounds from micro-organisms as well from higher plants. Current development of studies employing transgenic and/or recombinant technologies have opened up opportunities of the metabolic engineering/ metabolo-mics of biosynthetic pathways, leading to the growth of manufacturing of high-value secondary metabolites, even at the commercial level.

top of page

Publication History

Cite this article as

Corresponding author e-mail